... partners. Created by the Global Alliance for TB Drug Development, the Critical Path Institute, and the Bill ... continue to focus on innovation and accelerate the discovery and development of new compounds with new mechanisms of action, and at the same time work ... accelerate testing of new combination regimens as early as possible in development." Word of the collaboration came a day after a day ...

... -amyloid (Abeta) peptide in Alzheimer's disease and are therefore thought to be important drug targets for this disorder. Mutations in the presenilin genes cause early-onset familial Alzheimer&# ... and the effects of clinical mutations in the presenilin genes might help pave the way for improved development of drugs that are designed to target gamma-secretase enzymatic activity in Alzheimer's ...

... hired a whiz kid new head of business development who was told to do a deal in each of the five key areas, Alzheimer&# ... mechanism, which is probably best addressed via multiple pathways. The ideal drug would be one that is a small molecule, orally available, with an ability ... trade-off between tolerability and adverse event profile. Drug development, as we know, is a hugely risky endeavor. Animal ...

... right"/>Bad news on the Alzheimer’s drug development front: Pfizer and Medivation announced negative results ... potential milestone payments of as much as $500 million. The drug, considered to be the compound furthest along of those in development to treat Alzheimer’s, ... Briggs Morrison, who oversees Pfizer’s clinical development of late-stage Alzheimer’s compounds, told the ...

JGrimes Bad news on the Alzheimer’s drug development front: Pfizer and Medivation announced negative results ... potential milestone payments of as much as $500 million. The drug, considered to be the compound furthest along of those in development to treat Alzheimer’s, ... , Briggs Morrison, who oversees Pfizer’s clinical development of late-stage AlzheimerÂ’s compounds, told the ...

... at Genentech will work closely with UCSF to develop a drug candidate based on prior academic research conducted ... the potential for further funding in excess of $13 million, if certain development and commercial milestones are met, plus royalties. The agreement represents ... and creates a new model for important industry-academic drug development partnerships.” The partnership also coincides with ...

... is being paid to errors when it comes to dosage. This could affect all aspects of drug development and so it will be wise for pharmaceutical companies to keep abreast of FDA ... the counter medicines. It has been responsible for many accidental overdoses because patients do not know how much of the drug is in each pill they take and do not know the limit. The FDA is aiming to target this problem by ...

... their drug pipelines. Tuesday night, oncology-drug development firm Facet Biotech Corp. announced it had ... meeting with Ratiopharm executives. Also in the fight is Israeli generic-drug giant Teva Pharmaecutical Industries Inc. and Iceland’s Actavis ... same time would be a struggle for most companies in most industries. But in today’s drug industry, pharma giants need to be able to walk and chew gum at ...

Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, announced that Chugai Pharmaceutical Co., Ltd. (TSE: 4519) has exercised its right of first refusal for the development and commercialization in Japan of GDC-0449, a Hedgehog pathway inhibitor, under an existing ...

A struggling Durham drug development company hit another setback when its experimental pain medicine didn't help ... investors' expectations. Icagen also is testing the pain drug, known as ICA-105665, as a treatment for photosensitive epilepsy. Once ... the compound. That could include seeking permission from the U.S. Food and Drug Administration to test it as a pain treatment using higher doses. ...

... to jumpstart testing and approval of new regimens for so-called drug cocktails to combat tuberculosis, AIDS and cancer. The ... for life-threatening illnesses for which options don’t already exist, and that drug cocktails are believed necessary. Among those involved: the Critical Path to ... & Johnson; Global Alliance for TB Drug Development, the Critical Path Institute and Treatment Action ...

... Afghanistan, according to the report. The Taliban has access to parts of the drug trade in Pakistan, but its access is limited. Nor does the group ... ." Rural development is the administration's other important approach to combating the drug trade. "But ... border areas where the Taliban is strongest, rural development there has been slow in coming. In the north, marijuana has emerged as ...

... contracted AIDS. Undoubtedly most also had hepatitis C but didn't know it. And there was little interest in or sympathy for the drug using population on the part of medical professionals or government agencies, the ... example of Delaware, which does have such a set up. He also called for the inclusion of drug users in the development and improvement of services. (Frankly, this week is becoming ...

... Oriented Development (TOD) complete with a public plaza that offers convenient single serving drug ... promise: This is a $600 million Transit Oriented Development, funded with significant amounts of your (the public' ... Angeles and there will be more. Now is the time to raise the bar and to engage in development that is so brilliant that it causes those around the world to covet and envy, not to giggle ...

... Medical Center, located in Washington, DC, is a leader in the development of innovative new treatments for childhood illness and injury. About AVI BioPharmaAVI BioPharma is focused on the discovery and development of RNA-based medicines utilizing proprietary derivatives ... Muscular Dystrophy AVI BioPharma Signs an Additional Drug Development Contract With Charleys Fund Inc. for Duchenne Muscular ...